High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Implementation of gene editing technologies such as CRISPR/Cas9 in the manufacture of novel cell-based therapeutics has the potential to enable highly-targeted, stable, and persistent genome modifications without the use of viral vectors. Electroporation has emerged as a preferred method for delivering gene-editing machinery to target cells, but a major challenge remaining is that most commercial electroporation machines are built for research and process development rather than for large-scale, automated cellular therapy manufacturing. Here we present a microfluidic continuous-flow electrotransfection device designed for precise, consistent, and high-throughput genetic modification of target cells in cellular therapy manufacturing applications. We optimized our device for delivery of mRNA into primary human T cells and demonstrated up to 95% transfection efficiency with minimum impact on cell viability and expansion potential. We additionally demonstrated processing of samples comprising up to 500 million T cells at a rate of 20 million cells/min. We anticipate that our device will help to streamline the production of autologous therapies requiring on the order of 10$$^8$$ 8 –10$$^9$$ 9 cells, and that it is well-suited to scale for production of trillions of cells to support emerging allogeneic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Electrolysis can cause bubbling, leading to channel clogging, cell damage, and changes in the pH of the buffer.”
From Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines (2025) · cites this paper as [33]
In the citing paper
“However, this type of equipment faces challenges related to electrolysis at the electrodes.”
From Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines (2025) · cites this paper as [33]
In the citing paper
“The shape of this type of channel can be easily adjusted, and a small amount of sample liquid can be processed when using a narrow and short channel.”
From Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines (2025) · cites this paper as [33]
In the citing paper
“Several strategies have been proposed to mitigate these issues. They include applying a voltage below the redox potential [27], separating the electrode and cell suspension using a gel [22], and separating the flow of the cell suspension from the flow at the electrodes to prevent mixing of cells with lysed buffer [25,31,33].”
From Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines (2025) · cites this paper as [33]
In the citing paper
“Placing electrodes with a narrow gap in the microchannel path can also generate a locally intense electric field within the channel [22,25,27,31,33,36].”
From Gene electrotransfer with flow-through microchannel and lower alternating voltage generated induced pluripotent cells from human lymphoblastoid cell lines (2025) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207
KTE-X19 CAR T cell therapy in relapsed or refractory mantle-cell lymphoma
Wang, M., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., Timmerman, J. M., Holmes, H., Jaglowski, S., Flinn, I. W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914347 · Cited by 1,862
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
Reprogramming human T cell function and specificity with non-viral genome targeting
Roth, T. L., Puig-Saus, C., Yu, R., Shifrut, E., Carnevale, J., Li, P. J., Hiatt, J., Saco, J., Krystofinski, P., Li, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0326-5 · Cited by 839
Global Manufacturing of CAR T Cell Therapy
Levine, B. L., Miskin, J., Wonnacott, K., & Keir, C. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.12.006 · Cited by 765
Rupp, L. J., Schumann, K., Roybal, K. T., Gate, R. E., Ye, C. J., Lim, W. A., & Marson, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-00462-8 · Cited by 757
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
Schumann, K., Lin, S., Boyer, E., Simeonov, D. R., Subramaniam, M., Gate, R. E., Haliburton, G. E., Ye, C. J., Bluestone, J. A., Doudna, J. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512503112 · Cited by 702
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Clinical manufacturing of CAR T cells: foundation of a promising therapy
Wang, X., & Rivière, I. (2016) · Molecular Therapy - Oncolytics · doi:10.1038/mto.2016.15 · Cited by 637
Research works printed but not linked: 50
- Aijaz, A. et al. Biomanufacturing for clinically advanced cell therapies. Nat. Biomed. Eng. 2, 362–376. https://doi.org/10.1038/s41551-018-0246-6 (2018). · DOI · Paper page
- Kochenderfer, J. N. & Rosenberg, S. A. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat. Rev. Clin. Oncol. 10, 267–276. https://doi.org/10.1038/nrclinonc.2013.46 (2013). · DOI · Paper page
- Marcucci, K. T. et al. Retroviral and lentiviral safety analysis of gene-modified T cell products and infused HIV and oncology patients. Mol. Ther. 26, 269–279. https://doi.org/10.1016/j.ymthe.2017.10.012 (2018). · DOI · Paper page
- Moore, N. et al. A microfluidic device to enhance viral transduction efficiency during manufacture of engineered cellular therapies. Sci. Rep. 9, 15101. https://doi.org/10.1038/s41598-019-50981-9 (2019). · DOI
- Stewart, M. P., Langer, R. & Jensen, K. F. Intracellular delivery by membrane disruption: Mechanisms, strategies, and concepts. Chem. Rev. 118, 7409–7531. https://doi.org/10.1021/acs.chemrev.7b00678 (2018). · DOI · Paper page
- Felgner, P. L. & Ringold, G. M. Cationic liposome-mediated transfection. Nature 337, 387–388. https://doi.org/10.1038/337387a0 (1989). · DOI · Paper page
- Buttgereit, P. et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther. 7, 1145–1155. https://doi.org/10.1038/sj.cgt.7700209 (2000). · doi:10.1038/sj.cgt.7700209
- Sharei, A. et al. A vector-free microfluidic platform for intracellular delivery. Proc. Natl. Acad. Sci. USA 110, 2082–2087. https://doi.org/10.1073/pnas.1218705110 (2013). · DOI · Paper page
- Meacham, J. M., Durvasula, K., Degertekin, F. L. & Fedorov, A. G. Physical methods for intracellular delivery: Practical aspects from laboratory use to industrial-scale processing. J. Lab. Autom. 19, 1–18. https://doi.org/10.1177/2211068213494388 (2014). · DOI · Paper page
- Jarrell, J. A. et al. Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding. Sci. Rep. 9, 1–11. https://doi.org/10.1038/s41598-019-40147-y (2019). · DOI
- Kang, G. et al. Intracellular nanomaterial delivery via spiral hydroporation. ACS Nanohttps://doi.org/10.1021/acsnano.9b07930 (2020). · DOI
- Manuri, P. V. et al. PiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum. Gene Ther. 21, 427–437. https://doi.org/10.1089/hum.2009.114 (2010). · DOI · Paper page
- Chang, L. et al. Micro-/nano-scale electroporation. Lab. Chiphttps://doi.org/10.1039/C6LC00840B (2016). · DOI
- Geng, T. & Lu, C. Microfluidic electroporation for cellular analysis and delivery. Lab Chip 13, 3803–21. https://doi.org/10.1039/c3lc50566a (2013). · DOI
- Rols, M. P. & Teissié, J. Electropermeabilization of mammalian cells to macromolecules: Control by pulse duration. Biophys. J. 75, 1415–1423. https://doi.org/10.1016/S0006-3495(98)74060-3 (1998). · DOI · Paper page
- Rowley, J., Abraham, E., Campbell, A., Brandwein, H. & Oh, S. Meeting lot-size challenges of manufacturing adherent cells for therapy. BioProcess Int. 10, 7 (2012).
- Depil, S., Duchateau, P., Grupp, S. A., Mufti, G. & Poirot, L. ‘Off-the-shelf’ allogeneic CAR T cells: Development and challenges. Nat. Rev. Drug Discov.https://doi.org/10.1038/s41573-019-0051-2 (2020). · DOI · Paper page
- Wei, Z. et al. A laminar flow electroporation system for efficient DNA and siRNA delivery. Anal. Chem. 83, 5881–5887. https://doi.org/10.1021/ac200625b (2011). · DOI
- Zhu, T. et al. Electroporation based on hydrodynamic focusing of microfluidics with low dc voltage. Biomed. Microdevices 12, 35–40. https://doi.org/10.1007/s10544-009-9355-z (2010). · doi:10.1007/s10544-009-9355-z
- Hsi, P. et al. Acoustophoretic rapid media exchange and continuous-flow electrotransfection of primary human T cells for applications in automated cellular therapy manufacturing. Lab Chip 19, 2978–2992. https://doi.org/10.1039/C9LC00458K (2019). · DOI
- Franks, W., Schenker, I., Schmutz, P. & Hierlemann, A. Impedance characterization and modeling of electrodes for biomedical applications. IEEE Trans. Biomed. Eng. 52, 1295–1302 (2005). · DOI · Paper page
- Rosazza, C., Meglic, S. H., Zumbusch, A., Rols, M.-P. & Miklavcic, D. Gene electrotransfer: A mechanistic perspective. Curr. Gene Ther. 16, 98–129. https://doi.org/10.2174/1566523216666160331130040 (2016). · DOI · Paper page
- Jaroszeski, M. J., Heller, R., Rols, M.-P. & Teissié, J. Flow cytometry quantification of electropermeabilization. Flow Cytom. Protocols 97, 141–148. https://doi.org/10.1385/0-89603-354-6:141 (2003). · doi:10.1385/0-89603-354-6:141
- Weaver, J. C. & Chizmadzhev, Y. Theory of electroporation: A review. Bioelectrochem. Bioenergetics 41, 135–160. https://doi.org/10.1016/S0302-4598(96)05062-3 (1996). · DOI · Paper page
- Liu, F. et al. Mechanism of in vivo DNA transport into cells by electroporation: Electrophoresis across the plasma membrane may not be involved. J. Gene Med. 8, 353–361. https://doi.org/10.1002/jgm.851 (2006). · doi:10.1002/jgm.851
- Escoffre, J. M. et al. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol. Biotechnol. 41, 286–295. https://doi.org/10.1007/s12033-008-9121-0 (2009). · DOI · Paper page
- Wu, M. & Yuan, F. Membrane binding of plasmid DNA and endocytic pathways are involved in electrotransfection of mammalian cells. PLoS ONEhttps://doi.org/10.1371/journal.pone.0020923 (2011). · DOI · Paper page
- Chang, C. C., Wu, M. & Yuan, F. Role of specific endocytic pathways in electrotransfection of cells. Mol. Ther. Methods Clin. Dev. 1, 14058. https://doi.org/10.1038/mtm.2014.58 (2014). · DOI
- Cervia, L. D., Chang, C. C., Wang, L. & Yuan, F. Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection. PLoS ONE 12, 1–18. https://doi.org/10.1371/journal.pone.0171699 (2017). · DOI · Paper page
- Mao, M. et al. Involvement of a Rac1-dependent macropinocytosis pathway in plasmid DNA delivery by electrotransfection. Mol. Ther. 25, 803–815. https://doi.org/10.1016/j.ymthe.2016.12.009 (2017). · DOI
- Sachdev, S. et al. DNA-membrane complex formation during electroporation is DNA size-dependent. Biochim. Biophys. Acta Biomembr. 1862, 183089 (2020). · DOI
- Van Meirvenne, S. et al. Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther. 9, 787–797. https://doi.org/10.1038/sj.cgt.7700499 (2002). · DOI
- Bernhardt, J. & Pauly, H. On the generation of potential differences across the membranes of ellipsoidal cells in an alternating electrical field. Biophysik 10, 89–98. https://doi.org/10.1007/BF01189915 (1973). · DOI
- Rols, M. P. & Teissié, J. Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys. J. 58, 1089–1098. https://doi.org/10.1016/S0006-3495(90)82451-6 (1990). · DOI · Paper page
- Teissié, J. & Rols, M. P. An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys. J. 65, 409–413. https://doi.org/10.1016/S0006-3495(93)81052-X (1993). · DOI · Paper page
- Schwan, H. P. Biophysics of the Interaction of Electromagnetic Energy with Cells and Membranes. Biological Effects and Dosimetry of Nonionizing Radiation 213–231, https://doi.org/10.1007/978-1-4684-4253-3_9 (Springer, US, Boston) (1983). · doi:10.1007/978-1-4684-4253-3_9
- Tieleman, D. P. The molecular basis of electroporation. BMC Biochem. 5, 1–12. https://doi.org/10.1186/1471-2091-5-10 (2004). · DOI · Paper page
- Gowrishankar, T. R., Esser, A. T., Vasilkoski, Z., Smith, K. C. & Weaver, J. C. Microdosimetry for conventional and supra-electroporation in cells with organelles. Biochem. Biophys. Res. Commun. 341, 1266–1276. https://doi.org/10.1016/j.bbrc.2006.01.094 (2006). · DOI · Paper page
- Hibino, M., Itoh, H. & Kinosita, K. Time courses of cell electroporation as revealed by submicrosecond imaging of transmembrane potential. Biophys. J. 64, 1789–1800. https://doi.org/10.1016/S0006-3495(93)81550-9 (1993). · DOI · Paper page
- Zheng, M., Shan, J. W., Lin, H., Shreiber, D. I. & Zahn, J. D. Hydrodynamically controlled cell rotation in an electroporation microchip to circumferentially deliver molecules into single cells. Microfluidics Nanofluidics 20, 1–12. https://doi.org/10.1007/s10404-015-1691-0 (2016). · DOI
- Velaga, S. et al. Clinical-grade regulatory T cells: Comparative analysis of large-scale expansion conditions. Exp. Hematol. 45, 27-35.e1. https://doi.org/10.1016/j.exphem.2016.09.008 (2017). · doi:10.1016/j.exphem.2016.09.008
- Hedfors, I. A. & Brinchmann, J. E. Long-term proliferation and survival of in vitro-activated T cells is dependent on interleukin-2 receptor signalling but not on the high-affinity IL-2R. Scand. J. Immunol. 58, 522–532. https://doi.org/10.1046/j.1365-3083.2003.01338.x (2003). · DOI
- Hinkson, I. V. & Elias, J. E. The dynamic state of protein turnover: It’s about time. Trends Cell Biol. 21, 293–303. https://doi.org/10.1016/j.tcb.2011.02.002 (2011). · DOI
- Mathieson, T. et al. Systematic analysis of protein turnover in primary cells. Nat. Commun. 9, 1–10. https://doi.org/10.1038/s41467-018-03106-1 (2018). · DOI · Paper page
- Aksoy, B. A., Wyatt, M. & Paulos, C. M. Human primary T cells: A practical guide. PeerJ Preprints 28, 1–31. https://doi.org/10.7287/peerj.preprints.26993v1 (2018). · doi:10.7287/peerj.preprints.26993v1
- Kochenderfer, J. N. et al. Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell transplantation without causing graft-versus-host disease. J. Clin. Oncol. 34, 1112–1121. https://doi.org/10.1200/jco.2015.64.5929 (2016). · DOI · Paper page
- Zhao, D. et al. A Flow-Through Cell Electroporation Device for Rapidly and Efficiently Transfecting Massive Amounts of Cells in vitro and ex vivo. Sci. Rep. 6, 18469. https://doi.org/10.1038/srep18469 (2016). · DOI
- Wang, S., Zhang, X., Wang, W. & Lee, L. J. Semicontinuous flow electroporation chip for high-throughput transfection on mammalian cells. Anal. Chem. 81, 4414–4421. https://doi.org/10.1021/ac9002672 (2009). · DOI
- Adamo, A., Arione, A., Sharei, A. & Jensen, K. F. Flow-through comb electroporation device for delivery of macromolecules. Anal. Chem. 85, 1637–1641. https://doi.org/10.1021/ac302887a (2013). · DOI · Paper page
- MacLeod, D. T. et al. Integration of a CD19 CAR into the TCR alpha chain locus streamlines production of allogeneic gene-edited CAR T cells. Mol. Ther. 25, 949–961. https://doi.org/10.1016/j.ymthe.2017.02.005 (2017). · DOI · Paper page
Cited by
Ishii-Teshima, M., Maeda, K., Hanauchi, K., Asechi, E., Setyawan, D., Niki, T., Nakashima, K., Kurita, H., Numano, R., & Shibata, T. (2025) · PLOS One · doi:10.1371/journal.pone.0333491 · Cited by 4
Metadata
- Authors
- Lissandrello, C. A., Santos, J. A., Hsi, P., Welch, M., Mott, V. L., Kim, E. S., Chesin, J., Haroutunian, N. J., Stoddard, A. G., Czarnecki, A., Coppeta, J. R., Freeman, D. K., Flusberg, D. A., Balestrini, J. L., & Tandon, V.
- Venue
- Scientific Reports
- Published
- 2020-10-22
- Volume
- 10
- Issue
- 1
- ISSN
- 2045-2322
- Cited by
- 82
- References
- 14
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing. https://app.cochat.ai/papers/10.1038/s41598-020-73755-0
- The paper
- Lissandrello, C. A., Santos, J. A., Hsi, P., Welch, M., Mott, V. L., Kim, E. S., Chesin, J., Haroutunian, N. J., Stoddard, A. G., Czarnecki, A., Coppeta, J. R., Freeman, D. K., Flusberg, D. A., Balestrini, J. L., & Tandon, V. (2020). High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing. Scientific Reports. https://doi.org/10.1038/s41598-020-73755-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.